India outlines 14 "essential elements" of informed consent for drug trials
This article was originally published in Scrip
Executive Summary
Companies that are sponsors of clinical trials undertaken in India will have to abide be new requirements for informed consent documents. India's Central Drugs Standard Control Organization has laid out 14 "essential elements" that must be included in such documents used to enrol subjects in a drug trial.
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EMA Hopes New Requirement Will Make Companies Stick To Their Filing Plans
An additional form that marketing authorization applicants must now complete during the pre-submission stage emphasizes the importance of companies providing accurate information on their intended submission date.
EMA To Get The Ball Rolling On Making CTIS Global
The European Medicines Agency wants to further improve the visibility of data in the Clinical Trials Information System by establishing it as a World Health Organization primary registry.